Aggregate Evidence Quality . | Grade C . |
---|---|
Benefits | Avoid improper detection of MA in children with HTN. Detection of MA is strongly influenced by other factors, such as recent participation in rigorous physical activity, obesity, insulin resistance and diabetes. Hence, there is no clear benefit for testing for MA in the absence of other known comorbidities |
Risks, harm, cost | No known risks given a lack of clear association between MA and primary HTN in children |
Benefit–harm assessment | Limited data to support any real benefit for screening children for MA |
Intentional vagueness | Screening of children with primary HTN versus screening of children with single kidney or CKD and HTN |
Role of patient preferences | Unknown |
Exclusions | None |
Strength | Moderate recommendation |
Key references | 408,410,411,413 |
Aggregate Evidence Quality . | Grade C . |
---|---|
Benefits | Avoid improper detection of MA in children with HTN. Detection of MA is strongly influenced by other factors, such as recent participation in rigorous physical activity, obesity, insulin resistance and diabetes. Hence, there is no clear benefit for testing for MA in the absence of other known comorbidities |
Risks, harm, cost | No known risks given a lack of clear association between MA and primary HTN in children |
Benefit–harm assessment | Limited data to support any real benefit for screening children for MA |
Intentional vagueness | Screening of children with primary HTN versus screening of children with single kidney or CKD and HTN |
Role of patient preferences | Unknown |
Exclusions | None |
Strength | Moderate recommendation |
Key references | 408,410,411,413 |